PL1911746T3 - Substancja wykazująca działanie przeciwutleniające, przeciwstarzeniowe i przeciwniedokrwienne oraz sposób jej wytwarzania - Google Patents

Substancja wykazująca działanie przeciwutleniające, przeciwstarzeniowe i przeciwniedokrwienne oraz sposób jej wytwarzania

Info

Publication number
PL1911746T3
PL1911746T3 PL05807224T PL05807224T PL1911746T3 PL 1911746 T3 PL1911746 T3 PL 1911746T3 PL 05807224 T PL05807224 T PL 05807224T PL 05807224 T PL05807224 T PL 05807224T PL 1911746 T3 PL1911746 T3 PL 1911746T3
Authority
PL
Poland
Prior art keywords
geroprotective
antioxidant
substance
preparing
trimethyl
Prior art date
Application number
PL05807224T
Other languages
English (en)
Inventor
Leonid Dmitrievich Smipnov
Michail Arkadievich Ostrovsky
Aleksey Michailovich Sipyagin
Aleksandr Evgenievich Doncov
Original Assignee
Marvel Lifesciences Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Marvel Lifesciences Ltd filed Critical Marvel Lifesciences Ltd
Publication of PL1911746T3 publication Critical patent/PL1911746T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biochemistry (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL05807224T 2004-05-12 2005-07-11 Substancja wykazująca działanie przeciwutleniające, przeciwstarzeniowe i przeciwniedokrwienne oraz sposób jej wytwarzania PL1911746T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
RU2004114314/04A RU2276138C2 (ru) 2004-05-12 2004-05-12 Вещество, обладающее антиоксидантной, геропротекторной и противоишемической активностью, и способ его получения
PCT/IB2005/003636 WO2007017713A1 (fr) 2004-05-12 2005-07-11 Substance possedant un effet antioxydant, geroprotecteur et anti-ischemique et procede de fabrication correspondant
EP05807224A EP1911746B1 (en) 2004-05-12 2005-07-11 The substance having antioxidant, geroprotective and anti-ischemic activity and method for preparing thereof

Publications (1)

Publication Number Publication Date
PL1911746T3 true PL1911746T3 (pl) 2010-07-30

Family

ID=36021747

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05807224T PL1911746T3 (pl) 2004-05-12 2005-07-11 Substancja wykazująca działanie przeciwutleniające, przeciwstarzeniowe i przeciwniedokrwienne oraz sposób jej wytwarzania

Country Status (11)

Country Link
US (1) US8044210B2 (pl)
EP (1) EP1911746B1 (pl)
JP (1) JP2009501712A (pl)
CN (1) CN101233110B (pl)
AT (1) ATE440819T1 (pl)
BR (1) BRPI0520433A2 (pl)
CA (1) CA2614857A1 (pl)
DE (1) DE602005016317D1 (pl)
PL (1) PL1911746T3 (pl)
RU (1) RU2276138C2 (pl)
WO (1) WO2007017713A1 (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2276138C2 (ru) 2004-05-12 2006-05-10 Марвел Лайф Сайнсез Лтд. Вещество, обладающее антиоксидантной, геропротекторной и противоишемической активностью, и способ его получения
RU2326665C1 (ru) * 2007-04-03 2008-06-20 Марвел ЛайфСайнсез Лимитед, Великобритания Средство, обладающее противогипоксическим, противоинсультным, улучшающим память действием
EA011238B1 (ru) * 2007-04-03 2009-02-27 Марвел Лайфсайнсез Лтд. Средство, обладающее противогипоксическим, противоинсультным, улучшающим память действием
KR101214353B1 (ko) * 2007-12-18 2012-12-20 드미트리 발레리에비치 비류코프 치환된 3-히드록시피리딘 및 그것의 약학적 조성물
EP2265253A2 (en) * 2008-02-19 2010-12-29 Marvel Lifesciences Limited Oral dosage form containing a pyridinol derivative
EP2265252A2 (en) * 2008-02-19 2010-12-29 Marvel Lifesciences Limited Ophthalmic preparation containing a pyridinol derivate
WO2009116077A2 (en) * 2008-02-19 2009-09-24 M.J.Biopharm Pvt. Ltd. Injectable preparations and a process of preparation thereof
EA020371B1 (ru) 2012-07-19 2014-10-30 Хэндельсорт Аг Алкилзамещенные 3-гидроксипиридины для лечения депрессии
RU2671200C2 (ru) * 2015-12-07 2018-10-30 Закрытое Акционерное Общество "Фармфирма "Сотекс" Способ получения 6-метил-2-этилпиридин-3-ол соли (2S)-2-ацетаминопентандиовой кислоты

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2847926B2 (ja) * 1990-08-01 1999-01-20 トヨタ自動車株式会社 自動変速機の変速制御装置
JPH0496277A (ja) * 1990-08-06 1992-03-27 Fujitsu Ltd 不揮発性半導体記憶装置
IT1247528B (it) * 1991-04-24 1994-12-17 Medea Res Srl Composto ad attivita' terapeutica,sua preparazione e composizioni farmaceutiche che lo contengono
RU2070010C1 (ru) * 1993-08-31 1996-12-10 Эдуард Сергеевич Аветисов Средство антиоксидантной защиты сред и тканей глаза
RU2112512C1 (ru) 1995-09-22 1998-06-10 Иванов Евгений Васильевич Биологичеcки активная пищевая добавка "глутапирон", обладающая антиканцерогенным и геропротекторным действием
RU2153872C2 (ru) * 1997-10-15 2000-08-10 Амбалов Юрий Михайлович Способ лечения дифтерии
RU2197199C2 (ru) * 2000-05-12 2003-01-27 Государственное учреждение Межотраслевой научно-технический комплекс "Микрохирургия глаза" Способ лечения амблиопии
JP2002017295A (ja) * 2000-07-05 2002-01-22 Yamagami Suehito 眼疾患改善作用及び眼の機能維持作用を有する健康補助食品
RU2210568C1 (ru) * 2001-12-14 2003-08-20 Промоненков Виктор Кириллович Способ получения производных 2-этил-6-метил-3-гидроксипиридина
RU2250210C1 (ru) * 2003-07-25 2005-04-20 Институт Проблем Химической Физики Российской Академии Наук (Ипхф Ран) Нитроксисукцинат 2,4,6-триметил-3-оксипиридина и способ его получения
RU2276138C2 (ru) 2004-05-12 2006-05-10 Марвел Лайф Сайнсез Лтд. Вещество, обладающее антиоксидантной, геропротекторной и противоишемической активностью, и способ его получения

Also Published As

Publication number Publication date
EP1911746B1 (en) 2009-08-26
US8044210B2 (en) 2011-10-25
CN101233110A (zh) 2008-07-30
BRPI0520433A2 (pt) 2009-05-12
WO2007017713A1 (fr) 2007-02-15
DE602005016317D1 (de) 2009-10-08
US20090198068A1 (en) 2009-08-06
EP1911746A1 (en) 2008-04-16
CA2614857A1 (en) 2007-02-15
RU2276138C2 (ru) 2006-05-10
JP2009501712A (ja) 2009-01-22
ATE440819T1 (de) 2009-09-15
CN101233110B (zh) 2011-09-14

Similar Documents

Publication Publication Date Title
EP2361503A3 (en) N-2-(hetero)arylethylcarboxamide derivative, and pest-controlling agent comprising the same
EP1213296A4 (en) GLUCOPYRANOSYLOXYPYRAZOLE DERIVATIVES, MEDICINAL COMPOSITIONS CONTAINING SAID DERIVATIVES AND INTERMEDIATE PRODUCTS OBTAINED DURING THEIR PRODUCTION
DK0754672T3 (da) Gamma-Substitueret phenyleddikesyrederivat, fremgangsmåde til fremstilling deraf og landbrugsfungicid indeholdende samme
ATE497957T1 (de) Pyridinderivate als fungizide verbindungen
NO20091858L (no) Hydrobenzamid derivater som inhibitorer av HSP90
PT93063B (pt) Processo para a preparacao duma composicao insecticida contendo compostos organicos com grupos nitro
MX2007010532A (es) Derivados de amida de acido 1-sulfonil-piperidina-3-carboxilico como inhibidores de 11-beta-hidroxiesteroide deshidrogenasa para el tratamiento de diabetes mellitus tipo ii.
HU221038B1 (hu) Fungicid hatású, optikailag aktív 2-imidazolin-5-on és 2-imidazolin-5-tion-származékok, eljárás előállításukra, ezeket tartalmazó fungicid készítmények és alkalmazásuk
ATE358484T1 (de) Antidiabetische medikamente
BR0316902A (pt) Processos para preparar (+)duloxetina e hidrocloreto de (+)duloxetina, sal de ácido quiral e (+)duloxetina, di-p-toluil tartarato de (+)duloxetina, (+)duloxetina e composição farmacêutica
DE602006015231D1 (de) N-(1-alkyl-2-phenylethyl)carbonsäureamidderivate und deren verwendung als fungizide
Janczewski et al. Synthesis of isothiocyanates using DMT/NMM/TsO− as a new desulfurization reagent
DE602005016317D1 (de) Substanz mit oxidationshemmender, geroprotektiver und antiischämischer wirkung und verfahren zu deren herstellung
Shanzer et al. Total synthesis of enterobactin via an organotin template
CN114835596B (zh) Kakeromycin及其衍生物的制造方法
RU2005131735A (ru) Химические соединения
AR032230A1 (es) Derivado sulfonamida conteniendo una composicion agricola y horticola
Neumann et al. Preparation of 5-(cyclohexylmethyl) barbituric acid derivatives by acid-catalyzed reductive cyclohexylmethylation of barbituric acids with p-hydroxy or p-methoxybenzaldehydes
TNSN06233A1 (en) 7-phenylamino-4-quinolone-3-carboxylic acid derivatives, methods for production and use thereof as medicaments
PT916656E (pt) Metodo para producao de derivados de pirrolidinona
DE60230686D1 (de) Anthelmintische substanz fki-1033 und verfahren zur herstellung davon
JP2006513154A5 (pl)
IL169577A0 (en) Oligosaccharide derivatives and pharmaceutical compostions containing the same
KR20120080435A (ko) 전이금속 촉매하에서 산화제 및 산을 이용한 2-아미노아졸 화합물의 제조방법
EP1323714A1 (en) 1,3-selenazole derivatives and their use as anticancer drugs or as agrochemicals